BioAdaptives Inc. BDPT Archives

TuesdayOct 07, 2025 11:55 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTCMKTS: BDPT) Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand

BioAdaptives (OTCMKTS: BDPT) announced the commercial launch of MyndMed(TM), a next-generation dietary supplement designed to enhance memory, focus, and overall brain performance. Following extensive testing with highly positive user feedback, the company is scaling production and expanding distribution to meet anticipated high demand beginning in November. Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed(TM) delivers what the company calls “Mental Armor for Modern Minds(TM)” through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. Manufactured in the U.S. in cGMP-certified facilities and third-party tested for purity, MyndMed(TM) is available nationwide at www.MyndMed.com. To view…

WednesdayJul 16, 2025 9:30 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025

BioAdaptives (OTC Pink: BDPT), a wellness innovator, announced the national rollout of NeuroRush(TM), its next-generation nootropic aimed at enhancing mental clarity, cognitive endurance, and stress adaptability. Following strong results in test markets, the adaptogen-based formula will launch in August/September 2025 in two versions—one with natural caffeine and one caffeine-free. Formulated with clinically studied ingredients like Rhodiola, Ashwagandha, and Bacopa, NeuroRush(TM) supports brain health without the crash of stimulants. The product will be available online and through strategic wellness partners. To view the full press release, visit https://ibn.fm/R0VE2 About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the…

TuesdayJun 24, 2025 10:45 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum

BioAdaptives (OTC Pink: BDPT), a leader in nutraceutical and wellness innovation, will launch its proprietary canine supplement Pawpa(TM) Regen nationwide by the end of July 2025. Designed to support natural stem cell activation in aging dogs, the supplement has shown promising results in early trials, including improved energy, mobility, coat quality, and temperament. CEO James Keener emphasized the product’s unique regenerative approach using safe, naturally sourced ingredients. With strong early feedback and growing demand for holistic pet care solutions, BioAdaptives is expanding production ahead of the broader e-commerce rollout. To view the full press release, visit https://ibn.fm/Y6PRK About BioAdaptives, Inc.…

WednesdayMay 28, 2025 11:35 am

QualityStocksNewsBreaks – Bioadaptives Inc (BDPT) Showcases Breakthrough Stem Cell Benefits in Regen Dog Chews

Bioadaptives (BDPT), through its premium pet wellness division PawPa(TM), announced compelling clinical results for its flagship product Regen(TM) Dog Chews, formulated to naturally stimulate stem cell release and support canine vitality, mobility, and comfort. In veterinarian-led trials, Regen demonstrated a 281.3% increase in circulating stem cells after four weeks. The product's benefits are further measured using the company’s proprietary APBAR(R) rating system—modeled after the human APGAR score—helping pet owners track improvements in appearance, performance, behavior, attitude, and responsiveness. Crafted with all-natural ingredients including beneficial cyanobacteria and adaptogens, Regen(TM) is veterinarian-recommended, safe, and delivered in a tasty chew dogs love. With…

ThursdayMar 13, 2025 9:25 am

QualityStocksNewsBreaks – Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product

Bioadaptives (BDPT) announced the successful completion of dosage trials for Zeranovia™, its innovative weight loss product. Participants in the trial reported consistent weight loss of 5 to 7 pounds per week with minimal side effects, primarily mild gastrointestinal discomfort that was managed through dosage adjustments. With high participant satisfaction and all subjects eager to continue, BioAdaptives plans to refine dosing for the next phase of clinical trials, reinforcing its commitment to providing effective weight management solutions. To view the full press release, visit https://ibn.fm/Ho0gx About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness…

ThursdayFeb 06, 2025 1:40 pm

QualityStocksNewsBreaks – BioAdaptives Inc. (BDPT) Announces Board Appointment of UFC Senior Executive Reed Harris

BioAdaptives (OTC: BDPT), a leading biotechnology company focused on innovative health and wellness solutions, has announced the appointment of Reed Harris to its board of advisors. Harris, the senior VP of athlete development and marketing at the Ultimate Fighting Championship (“UFC”) in Las Vegas, brings decades of experience in leadership, athlete development and business management, as well as a proven commitment to driving innovation and excellence. “Reed’s exceptional leadership, business acumen and dedication to athlete development and community service align perfectly with our mission to deliver innovative health and wellness solutions,” said Jim Keener, CEO of BioAdaptives. “His deep experience…

TuesdayDec 10, 2024 1:40 pm

QualityStocksNewsBreaks – BioAdaptives Inc. (BDPT) Launches Xcellara(TM) — an Innovative Supplement That Harnesses Nature for Optimal Health

BioAdaptives (OTC: BDPT) today announced the launch of Xcellara(TM) Stem Cell Activator, a groundbreaking supplement that harnesses the extraordinary potential of stem cells' regeneration power through a blend of adaptogens, herbs and beneficial bacteria. The innovative formulation supports the body's natural repair mechanisms, promoting anti-aging and enhancing overall health and wellness. "This is an exciting milestone for BioAdaptives as we continue to push the boundaries of what's possible in natural health supplements," said the company’s CEO James Keener. "With the launch of Xcellara(TM) Stem Cell Activator, we're offering a product that's both innovative and deeply rooted in science, leveraging a…

WednesdayNov 13, 2024 12:35 pm

QualityStocksNewsBreaks – BioAdaptives Inc. (BDPT) Unveils New Suite of Next-Gen Nutritional Products

BioAdaptives (OTC: BDPT), a leading provider of innovative nutritional products, today announced a transformative shift in its product lineup, replacing its entire portfolio of legacy products with a new suite of scientifically advanced solutions. The strategic move aims to deliver enhanced customer value, aligning each new offering directly with identified market needs through a rigorous product-market-fit approach. The redesigned lineup includes nutritional products for weight management, wellness, muscle and tissue repair, anti-aging for humans and Paw Partners, each developed with advanced scientific research and tailored to address specific pain points in the marketplace. “We are excited to introduce our new…

ThursdayMay 30, 2024 3:43 pm

QualityStocksNewsBreaks – BioAdaptives, Inc. (BDPT) Appoints Car Rental Industry Veteran to Its Board of Directors

BioAdaptives (OTC: BDPT), a leader in the health and wellness sector, is announcing the appointment of Gimhana Dissanayake to its Board of Directors. According to the announcement, Gimhana brings over two decades of comprehensive experience and a proven track record of strategic growth and operational excellence to the company. He currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ). With an illustrious career that has spanned various leadership positions at Hertz, Gimhana is renowned for his strategic vision and leadership acumen. The announcement noted that his educational background and extensive professional…

Site Search

Company Search

Tag: BioAdaptives Inc. BDPT